4
Changes in Ownership
Indaptus Therapeutics, Inc. Filed Acc 0001493152-25-029356
Chief Financial Officer acquired 26,758 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sassi Nir Chief Financial Officer | 2025-12-22 | Grant or award | +26,758 | $2.03 | $54,319 | 26,758 | D |
Loading xslF345X05/ownership.xml…